Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
FDA permits marketing of ClonoSEQ assay to detect minimal residual disease in blood cancer patients

FDA permits marketing of ClonoSEQ assay to detect minimal residual disease in blood cancer patients

Cancer undercuts ability of normal cells to consume glucose, finds study

Cancer undercuts ability of normal cells to consume glucose, finds study

Researchers design new combination therapy for reducing NSCLC cell growth

Researchers design new combination therapy for reducing NSCLC cell growth

Loyola announces plans to produce CAR-T cells for treating cancer

Loyola announces plans to produce CAR-T cells for treating cancer

Verastem Oncology selects US Bioservices to dispense COPIKTRA capsules

Verastem Oncology selects US Bioservices to dispense COPIKTRA capsules

UCI researchers receive $3.4 million grant to study new class of cancer killing immunotherapeutics

UCI researchers receive $3.4 million grant to study new class of cancer killing immunotherapeutics

CytoSen receives favorable response from FDA to its pre-IND meeting package for CSTD002-NK

CytoSen receives favorable response from FDA to its pre-IND meeting package for CSTD002-NK

Lower clinical trial enrollment associated with relapse risk in AYA leukemia patients

Lower clinical trial enrollment associated with relapse risk in AYA leukemia patients

Rutgers study uncovers new mechanism linked to Alzheimer's and traumatic brain injury

Rutgers study uncovers new mechanism linked to Alzheimer's and traumatic brain injury

New approach for bone marrow transplant could make it safer and more effective for patients

New approach for bone marrow transplant could make it safer and more effective for patients

Research shows possibility to postpone cumbersome treatment for low-risk MDS patients

Research shows possibility to postpone cumbersome treatment for low-risk MDS patients

New research suggests power of zebrafish as tool for cancer drug discovery

New research suggests power of zebrafish as tool for cancer drug discovery

CHMP grants positive opinion for VENCLYXTO plus rituximab for treating relapsed/refractory CLL

CHMP grants positive opinion for VENCLYXTO plus rituximab for treating relapsed/refractory CLL

New guidance for treatment of bone loss in hematologic stem cell transplant Recipients

New guidance for treatment of bone loss in hematologic stem cell transplant Recipients

FDA approves new treatment for people with hairy cell leukemia

FDA approves new treatment for people with hairy cell leukemia

Study: Children with acute lymphoblastic leukemia are immunologically disparate at birth

Study: Children with acute lymphoblastic leukemia are immunologically disparate at birth

Scientists get unprecedented view of brain development through high-resolution genomic map

Scientists get unprecedented view of brain development through high-resolution genomic map

Novel treatment for hairy cell leukemia approved by FDA

Novel treatment for hairy cell leukemia approved by FDA

Drug combination targets pre-leukemia stem cells

Drug combination targets pre-leukemia stem cells

New study links stress with biological disease markers in leukemia patients

New study links stress with biological disease markers in leukemia patients